Agilent Completes Acquisition of BIOVECTRA
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics. Read More
Agilent Completes Acquisition of BIOVECTRA
Agilent Completes Acquisition of BIOVECTRA
Agilent Completes Acquisition of BIOVECTRA
Agilent Completes Acquisition of BIOVECTRA
Agilent Completes Acquisition of BIOVECTRA
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute